drugset / Trial / NCT00108238
Estrogen Alternatives Study
RandomizedParallel-groupDouble-blindPrevention
Summary
Healthy postmenopausal women not currently taking hormone replacement or hormone modulating therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each on vascular function, as indicated by PET coronary flow reserve studies and brachial artery ultrasound, before and after use of the therapies. This is a randomized, placebo-controlled, blinded study.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | — | — |
| Subject | Raloxifene | Other / unclassified | — | — |
| Background | Progesterone | Other / unclassified | — | — |
Indications
No indication recorded.